Chewy: Gordon Haskett drops coverage on the stock.
Coinbase Global: Oppenheimer upgrades to outperform from market perform with a target price of USD 160.
Fair Isaac: Barclays maintains its overweight recommendation and raises the target price from USD 1234 to USD 1500.
Humana: Nephron Research…
© MarketScreener.com 2024
Coinbase Global: Oppenheimer upgrades to outperform from market perform with a target price of USD 160.
Fair Isaac: Barclays maintains its overweight recommendation and raises the target price from USD 1234 to USD 1500.
Humana: Nephron Research…
© MarketScreener.com 2024